Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. SC TO-C Deal Written Communication Relating to an Issuer
  2. 3 Insider Initial Statement of Ownership
  3. SCHEDULE 13D Stake Beneficial Ownership Report
  4. 8-K Event Results of operations
  5. SC TO-C Deal Written Communication Relating to an Issuer
  6. 4 Shares withheld for taxes Chief Accounting Officer gave up 54 shares (to pay taxes)
  7. SC TO-C Deal Written Communication Relating to an Issuer
  8. 8-K Event Material agreement · Other events
  9. SC TO-C Deal Written Communication Relating to an Issuer
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 8-K Event Executive or director change
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Head of Pharm Ops and Tech bought 3 shares at $195.04 ($585)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 137 · 2,721 filings